Solutions & Services
Therapeutic expertise
Why APICES
Oncology trials place immediate pressure on execution. Protocols are complex, eligibility criteria are narrow, and patient populations are fragmented across competing studies. Feasibility is rarely limited by prevalence alone, but by timing, investigator prioritization, and the ability of sites to absorb another demanding protocol.
APICES brings oncology expertise grounded in running studies where these pressures are real. We understand how standards of care evolve during study conduct, how overlapping trials affect recruitment dynamics, and which sites consistently deliver in competitive landscapes. This experience informs early design decisions, realistic feasibility assessments, and focused site selection.
Our oncology work emphasizes control over scale. Rather than expanding countries or sites reactively, we align study design and operational strategy with where recruitment can realistically be delivered. This reduces the risk of delayed start-up, underperforming sites, and mid-study rescue actions.
For sponsors, this means oncology studies that are planned with execution reality in mind, and delivered with fewer surprises once they are live.
Talk to our team about how execution realities may shape the feasibility and timelines of your oncology study.
When moving from protocol to first European execution →
When scale, consistency, and delivery discipline matter →